Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 292.5	$ 289.2
Trade and other accounts receivable (less allowances of $11.8 million and $11.9 million, respectively)	342.3	341.7
Inventories (less allowances of $40.4 million and $34.6 million, respectively):
Finished goods	226.3	197.9
Raw materials	103.0	103.1
Total inventories	329.3	301.0
Prepaid expenses	20.1	21.0
Prepaid income taxes	13.1	3.1
Other current assets	7.3	0.6
Total current assets	1,004.6	956.6
Net property, plant and equipment	286.1	269.7
Operating leases right-of-use assets	52.7	44.8
Goodwill	399.0	382.5
Other intangible assets	67.7	65.4
Deferred tax assets	13.6	9.4
Pension asset	0.0	2.4
Other non-current assets	8.7	3.9
Total assets	1,832.4	1,734.7
Current liabilities:
Accounts payable	174.7	163.8
Accrued liabilities	152.3	169.1
Current portion of operating lease liabilities	15.9	13.9
Current portion of plant closure provisions	4.9	5.0
Current portion of acquisition-related contingent consideration	7.0	0.0
Current portion of accrued income taxes	5.3	19.6
Total current liabilities	360.1	371.4
Operating lease liabilities, net of current portion	36.8	31.0
Plant closure provisions, net of current portion	60.2	55.3
Deferred tax liabilities	19.1	23.5
Pension liabilities and post-employment benefits	13.2	13.1
Acquisition-related contingent consideration	1.3	20.1
Other non-current liabilities	8.8	4.2
Total liabilities	499.5	518.6
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	376.5	369.9
Treasury stock (4,776,918 and 4,594,943 shares at cost, respectively)	(115.2)	(93.0)
Retained earnings	1,099.2	1,025.0
Accumulated other comprehensive loss	(34.7)	(91.0)
Total Innospec stockholders' equity	1,326.1	1,211.2
Non-controlling interest	6.8	4.9
Total equity	1,332.9	1,216.1
Total liabilities and equity	$ 1,832.4	$ 1,734.7